Advertisement

Advertisement
Gynecologic Cancers

One-Dose HPV Vaccination Approach May Help to Eliminate Cervical Cancer

Canadian vaccination programs may switch to a one-dose, gender-neutral human papillomavirus (HPV) vaccination approach to eliminate cervical cancer, according to a recent study published by Drolet et al in the Canadian Medical Association Journal.


Prostate Cancer

Can Blood Test Predict Survival in Metastatic Prostate Cancer?

A recent study found that measuring circulating tumor cells (CTCs) is a reliable way to predict later treatment response and survival prospects in men when metastatic prostate cancer is first diagnosed. The test may help providers to decide which patients should receive standard treatment vs who might stand to benefit from new drug trials. The research, part of a phase III clinical trial funded in part by the National Cancer Institute (NCI) of the National Institutes of Health, was published by Goldkorn et al in JAMA Network Open.

 

Lung Cancer

Stereotactic vs Hypofractionated Radiotherapy for Inoperable Stage I NSCLC

As reported in JAMA Oncology by Swaminath et al, the Canadian phase III LUSTRE trial has shown no significant benefit in local tumor control with stereotactic body radiotherapy (SBRT) vs hypofractionated conventional radiotherapy (CRT) in patients with inoperable stage I non–small cell lung cancer (NSCLC).


Advertisement
Issues in Oncology

Bridging the Gap in Cancer Clinical Trial Funding

In a Journal of Clinical Oncology editorial, Yara Abdou, MD, and Norman E. Sharpless, MD, responded to a recent study by the Fred Hutchinson Cancer Center in Seattle that found enrollment in industry-sponsored cancer clinical trials doubled between 2008 and 2022, whereas federally supported trial enrollment remained flat. From 2018 to 2022, cancer clinical trial enrollment was eight times greater in industry-sponsored studies than in federal studies.

 

Survivorship

Exercise Linked to Fewer Falls in Older Adults With Cancer

A recent study suggests that for people older than age 65 who have cancer, physical activity may be key to reducing the chances of a dangerous fall. People with lung cancer, colorectal cancer, or prostate cancer, in particular, had a lower risk of falling when they talked with their doctor about physical activity, according to findings from the study. This finding is important because people with these types of cancer generally have a higher risk of falling, which may be due to the location of the cancer or the different types of treatments used, such as surgery or radiation therapy. The findings from this study were presented at the 2024 ASCO Quality Care Symposium.

Advertisement
Advertisement




Sponsored Content

More Top Stories


Hematologic Malignancies

Rami S. Komrokji, MD, on Myelodysplastic Neoplasms: Classifying Risks Among Subsets of Disease

Global Cancer Care

Shared Reflections on the 2024 ASCO Annual Meeting: From Networking to Mentorship and More

The ASCO Annual Meeting brings together oncologists, researchers, and health-care professionals to share the latest advancements in cancer care. The 2024 ASCO Annual Meeting (ASCO24) was particularly momentous for those of who received the international development and education award (IDEA). As...

Advertisement

Bridging the Gap in Cancer Clinical Trial Funding

In a Journal of Clinical Oncology editorial, Yara Abdou, MD, and Norman E. Sharpless, MD, responded to a recent study by the Fred Hutchinson Cancer Center in Seattle that found enrollment in industry-sponsored cancer clinical trials doubled between 2008 and 2022, whereas federally supported trial ...

Paolo Corradini, MD, on PMBCL and DLBCL: Comparing Outcomes With Axicabtagene Ciloleucel

Legislation

Cancer Provider Groups Across the Country Urge Congress to Pass Prior Authorization Reform

The Association for Clinical Oncology (ASCO), along with 46 state oncology societies, sent a letter to U.S. House and Senate leadership urging Congress to pass the Improving Seniors’ Timely Access to Care Act (H.R. 8702/S. 4532), which would streamline prior authorization practices within Medicare...

Genomics/Genetics

Coping With the Risk of Hereditary Cancer

All these preventive strategies to avoid cancer or to catch it early have made me feel both in control and out of control of my health. — Frances Merrill Tweet this quote Three years ago, it had become clear that I needed to be tested for the BRCA1/2 mutation. I knew...

Can Blood Test Predict Survival in Metastatic Prostate Cancer?

A recent study found that measuring circulating tumor cells (CTCs) is a reliable way to predict later treatment response and survival prospects in men when metastatic prostate cancer is first diagnosed. The test may help providers to decide which patients should receive standard treatment vs who...

Hematologic Malignancies
Leukemia

Nigel Russell, MD, on Acute Myeloid Leukemia: New Findings on FLAG-Ida and Gemtuzumab Ozogamicin

Ann Partridge, MD, MPH, Receives ESMO Award for Significant Contributions to Breast Cancer Research and Patient Care

Ann Partridge, MD, MPH Ann Partridge, MD, MPH, of Dana-Farber Cancer Institute, was named the recipient of the 2024 ESMO Award during the opening session of the European Society for Medical Oncology (ESMO) Congress 2024 in Barcelona. The international award recognizes her work and commitment...

Advertisement

One-Dose HPV Vaccination Approach May Help to Eliminate Cervical Cancer

Canadian vaccination programs may switch to a one-dose, gender-neutral human papillomavirus (HPV) vaccination approach to eliminate cervical cancer, according to a recent study published by Drolet et al in the Canadian Medical Association Journal. Background HPV is known to cause cervical cancer...

ASCO Post X Feed
Social Media Hub by Everwall